Overview
Humana Inc., based in the United States, operates primarily within the healthcare industry, focusing on health insurance services. As a major player in the sector, Humana is dedicated to managing health care coverage for its members and administering a diverse range of health, wellness, and insurance solutions, including Medicare Advantage, Prescription Drug Plans, and Tricare. Notably, Humana also engages in key projects aimed at addressing chronic health conditions and supporting public health. The company is continuously involved in initiatives and partnerships that innovate and enhance healthcare accessibility and quality, aligning with evolving market dynamics and regulatory frameworks to better serve its clients and stakeholders.
Basic Stats
The share price of Humana Inc. as of September 5, 2025 is $307.92 / share. This is an increase of 1.40% from the prior week. The market cap (or net worth) of Humana Inc. as of September 5, 2025 is $37,034.10 MM.
The Factor Analysis chart (below right) shows a view of Humana Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 37,034.10 MM |
| EV | 46,482.42 MM |
| Shares Out. | 120.27 MM |
| Earnings Date | |
| EPS (TTM) | 13.10 |
| Dividend Yield | 1.15 % |
| Ex-Dividend Date | 2025-09-26 |
| Borrow Rate | 0.41 |
| Short Shares Avail. | 1.80 MM |
| Short Interest | 5.27 MM |
| Short Float | 4.39 % |
| Days to Cover | 3.64 days |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | -15.75 % |
| Volatility (1 yr) | 0.45 |
| Beta | 1.05 |
| Sharpe Ratio (1 yr) | -0.44 |
| Sortino Ratio (1 yr) | -0.68 |
| PE Ratio | 23.48 |
| Price/Book | 2.02 |
| Price/TBV | 4.30 |
| Book/Market | 0.49 |
| EBIT/EV | 0.05 |
| EBIT(3yr avg)/EV | 0.06 |
| ROA | 0.03 |
| ROE | 0.09 |
| ROIC | 0.05 |
| CROIC | -0.05 |
| OCROIC | 0.09 |
| Implied Volatility | 40.98 % |
| Put/Call OI Ratio | 0.65 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Humana Inc. is $294.74. The forecasts range from a low of $252.50 to a high of $361.20. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Humana Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2022-12-13 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2022-11-10 | Mizuho | Buy | Maintains | |
| 2022-11-03 | SVB Leerink | Outperform | Maintains | |
| 2022-11-03 | RBC Capital | Outperform | Maintains | |
| 2022-11-03 | Goldman Sachs | Neutral | Maintains | |
| 2022-11-03 | Credit Suisse | Outperform | Maintains | |
| 2022-10-31 | Morgan Stanley | Overweight | Maintains | |
| 2022-10-26 | Deutsche Bank | Hold | Buy | Upgrade |
| 2022-09-20 | RBC Capital | Outperform | Maintains | |
| 2022-09-20 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2022-09-16 | Truist Securities | Hold | Maintains | |
| 2022-09-16 | Oppenheimer | Outperform | Maintains | |
| 2022-08-02 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-07-28 | SVB Leerink | Outperform | Maintains | |
| 2022-07-28 | Oppenheimer | Outperform | Maintains | |
| 2022-07-28 | Mizuho | Buy | Maintains | |
| 2022-07-28 | Barclays | Overweight | Maintains | |
| 2022-07-14 | Truist Securities | Hold | Maintains | |
| 2022-06-17 | Loop Capital | Buy | Initiate | |
| 2022-05-25 | Wells Fargo | Overweight | Maintains | |
| 2022-04-28 | Wells Fargo | Overweight | Maintains | |
| 2022-04-28 | SVB Leerink | Outperform | Maintains | |
| 2022-04-28 | RBC Capital | Outperform | Maintains | |
| 2022-04-13 | UBS | Neutral | Buy | Upgrade |
| 2022-03-09 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-02-03 | SVB Leerink | Outperform | Maintains | |
| 2022-01-07 | Wells Fargo | Overweight | Maintains | |
| 2022-01-07 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-01-07 | Barclays | Overweight | Maintains | |
| 2022-01-06 | Wells Fargo | Equal-Weight | Overweight | Upgrade |
| 2022-01-05 | Truist Securities | Hold | Maintains | |
| 2021-12-17 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2021-12-16 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2021-12-14 | Goldman Sachs | Neutral | Initiate | |
| 2021-11-10 | Mizuho | Buy | Maintains | |
| 2021-11-10 | Deutsche Bank | Hold | Maintains | |
| 2021-11-04 | SVB Leerink | Outperform | Maintains | |
| 2021-11-04 | RBC Capital | Outperform | Maintains | |
| 2021-11-04 | Oppenheimer | Outperform | Maintains | |
| 2021-11-04 | Morgan Stanley | Overweight | Maintains | |
| 2021-11-04 | Credit Suisse | Outperform | Maintains | |
| 2021-11-04 | Barclays | Overweight | Maintains | |
| 2021-09-27 | SVB Leerink | Outperform | Initiate | |
| 2021-09-09 | Barclays | Overweight | Reiterate | |
| 2021-08-31 | Morgan Stanley | Overweight | Maintains | |
| 2021-07-09 | Seaport Global | Neutral | Initiate | |
| 2021-05-19 | Wells Fargo | Equal-Weight | Initiate | |
| 2021-04-29 | Oppenheimer | Outperform | Maintains | |
| 2021-04-29 | Citigroup | Buy | Maintains | |
| 2021-01-04 | RBC Capital | Sector Perform | Outperform | Upgrade |
| 2020-11-30 | SVB Leerink | Outperform | Maintains | |
| 2020-11-04 | Credit Suisse | Outperform | Maintains | |
| 2020-10-02 | Bernstein | Market Perform | Initiate | |
| 2020-10-01 | Piper Sandler | Overweight | Maintains | |
| 2020-09-10 | Deutsche Bank | Hold | Maintains | |
| 2020-08-06 | SVB Leerink | Outperform | Maintains | |
| 2020-08-06 | Piper Sandler | Overweight | Maintains | |
| 2020-07-01 | SVB Leerink | Outperform | Initiate | |
| 2020-06-16 | Cowen & Co. | Outperform | Market Perform | Downgrade |
| 2020-06-05 | Goldman Sachs | Buy | Initiate | |
| 2020-05-21 | SunTrust Robinson Humphrey | Hold | Maintains | |
| 2020-04-30 | Oppenheimer | Outperform | Maintains | |
| 2020-04-30 | Morgan Stanley | Overweight | Maintains | |
| 2020-04-30 | Credit Suisse | Outperform | Maintains | |
| 2020-04-30 | Citigroup | Buy | Maintains | |
| 2020-04-13 | Morgan Stanley | Overweight | Maintains | |
| 2020-03-27 | Morgan Stanley | Overweight | Maintains | |
| 2020-02-18 | Deutsche Bank | Hold | Maintains | |
| 2020-02-06 | Morgan Stanley | Overweight | Maintains | |
| 2020-02-06 | Mizuho | Buy | Maintains | |
| 2020-02-06 | Deutsche Bank | Buy | Maintains | |
| 2020-02-05 | Cantor Fitzgerald | Overweight | Reiterate | |
| 2020-01-23 | UBS | Neutral | Maintains | |
| 2020-01-08 | Credit Suisse | Outperform | Maintains | |
| 2020-01-03 | JP Morgan | Overweight | Maintains | |
| 2020-01-03 | Goldman Sachs | Buy | Maintains | |
| 2019-12-20 | JP Morgan | Overweight | Maintains | |
| 2019-12-18 | SunTrust Robinson Humphrey | Hold | Maintains | |
| 2019-12-11 | Wells Fargo | Overweight | Maintains | |
| 2019-12-06 | Barclays | Overweight | Maintains | |
| 2019-11-18 | SunTrust Robinson Humphrey | Hold | Maintains | |
| 2019-11-18 | Morgan Stanley | Overweight | Maintains | |
| 2019-11-12 | UBS | Neutral | Maintains | |
| 2019-11-07 | Citigroup | Buy | Maintains | |
| 2019-10-18 | Mizuho | Buy | Initiate | |
| 2019-09-30 | BMO Capital | Outperform | Market Perform | Downgrade |
| 2019-09-26 | Morgan Stanley | Overweight | Maintains | |
| 2019-09-12 | Deutsche Bank | Hold | Initiate | |
| 2019-08-23 | Morgan Stanley | Overweight | Maintains | |
| 2019-08-12 | Cantor Fitzgerald | Neutral | Overweight | Upgrade |
| 2019-08-01 | UBS | Neutral | Maintains | |
| 2019-08-01 | Piper Jaffray | Overweight | Maintains | |
| 2019-08-01 | JP Morgan | Overweight | Maintains | |
| 2019-07-12 | Morgan Stanley | Overweight | Maintains | |
| 2019-05-02 | Citigroup | Buy | Buy | Maintains |
| 2019-04-23 | UBS | Neutral | Initiate | |
| 2019-04-17 | Barclays | Overweight | Overweight | Maintains |
| 2019-02-07 | Citigroup | Buy | Buy | Maintains |
| 2019-01-14 | Stephens & Co. | Overweight | Initiate | |
| 2019-01-11 | Cowen & Co. | Market Perform | Outperform | Upgrade |
| 2018-12-20 | JP Morgan | Neutral | Overweight | Upgrade |
| 2018-11-08 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2018-11-08 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-11-08 | Jefferies | Buy | Buy | Maintains |
| 2018-11-08 | Credit Suisse | Outperform | Outperform | Maintains |
| 2018-09-17 | Cowen & Co. | Market Perform | Initiate | |
| 2018-09-13 | Barclays | Overweight | Initiate | |
| 2018-09-05 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-08-02 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2018-08-02 | Jefferies | Buy | Buy | Maintains |
| 2018-08-02 | Bank of America | Buy | Buy | Maintains |
| 2018-06-25 | BMO Capital | Outperform | Outperform | Maintains |
| 2018-04-16 | Argus | Buy | Buy | Maintains |
| 2018-02-12 | JP Morgan | Neutral | Neutral | Maintains |
| 2018-02-09 | Deutsche Bank | Hold | Hold | Maintains |
| 2018-02-08 | Credit Suisse | Neutral | Outperform | Upgrade |
| 2018-01-12 | Jefferies | Hold | Buy | Upgrade |
| 2018-01-03 | Goldman Sachs | Buy | Initiate | |
| 2017-11-10 | Credit Suisse | Neutral | Maintains | |
| 2017-11-10 | BMO Capital | Outperform | Maintains | |
| 2017-11-09 | Morgan Stanley | Overweight | Maintains | |
| 2017-11-02 | Credit Suisse | Neutral | Initiate | |
| 2017-10-17 | BMO Capital | Outperform | Initiate | |
| 2017-10-09 | JP Morgan | Overweight | Neutral | Downgrade |
| 2017-08-17 | Morgan Stanley | Overweight | Maintains | |
| 2017-08-07 | Deutsche Bank | Hold | Maintains | |
| 2017-07-14 | Bank of America | Buy | Maintains | |
| 2017-06-28 | Citigroup | Buy | Initiate | |
| 2017-06-09 | Argus | Hold | Buy | Upgrade |
| 2017-06-07 | Morgan Stanley | Overweight | Initiate | |
| 2017-04-21 | Jefferies | Buy | Hold | Downgrade |
| 2017-04-05 | Deutsche Bank | Hold | Initiate | |
| 2017-01-24 | Stifel Nicolaus | Buy | Hold | Downgrade |
| 2017-01-04 | PiperJaffray | Overweight | Initiate | |
| 2016-12-07 | Cantor Fitzgerald | Buy | Hold | Downgrade |
| 2016-11-11 | Credit Suisse | Neutral | Outperform | Upgrade |
| 2016-11-10 | JP Morgan | Neutral | Overweight | Upgrade |
| 2016-09-23 | Evercore ISI Group | Buy | Initiate | |
| 2016-08-16 | Credit Suisse | Neutral | Maintains | |
| 2016-08-04 | Jefferies | Buy | Maintains | |
| 2016-08-04 | Barclays | Equal-Weight | Maintains | |
| 2016-07-21 | Credit Suisse | Neutral | Maintains | |
| 2016-07-18 | Jefferies | Hold | Buy | Upgrade |
| 2015-12-16 | Credit Suisse | Neutral | Initiate | |
| 2015-09-16 | JP Morgan | Overweight | Initiate | |
| 2015-09-08 | RBC Capital | Sector Perform | Maintains | |
| 2015-07-09 | Susquehanna | Neutral | Maintains | |
| 2015-07-07 | Argus Research | Hold | Downgrade | |
| 2015-07-07 | Argus | Buy | Hold | Downgrade |
| 2015-07-06 | Wedbush | Outperform | Neutral | Downgrade |
| 2015-07-02 | Argus Research | Buy | Maintains | |
| 2015-07-02 | Argus | Buy | Maintains | |
| 2015-06-24 | RBC Capital | Sector Perform | Initiate | |
| 2015-06-03 | Sterne Agee CRT | Underperform | Neutral | Upgrade |
| 2015-06-01 | Leerink Swann | Outperform | Maintains | |
| 2015-06-01 | Deutsche Bank | Hold | Maintains | |
| 2015-06-01 | Cantor Fitzgerald | Buy | Maintains | |
| 2015-05-13 | Sterne Agee CRT | Neutral | Underperform | Downgrade |
| 2015-05-07 | Leerink Swann | Outperform | Maintains | |
| 2015-05-01 | Oppenheimer | Outperform | Maintains | |
| 2015-04-30 | Jefferies | Hold | Maintains | |
| 2015-04-30 | Deutsche Bank | Hold | Maintains | |
| 2015-04-30 | Barclays | Equal-Weight | Maintains | |
| 2015-03-20 | Barclays | Equal-Weight | Maintains | |
| 2015-01-08 | Barclays | Equal-Weight | Maintains | |
| 2015-01-06 | Deutsche Bank | Sell | Hold | Upgrade |
| 2015-01-05 | Raymond James | Outperform | Market Perform | Downgrade |
| 2014-12-05 | JP Morgan | Overweight | Maintains | |
| 2014-12-05 | Bank of America | Neutral | Maintains | |
| 2014-11-18 | Bank of America | Neutral | Maintains | |
| 2014-11-11 | Citigroup | Sell | Maintains | |
| 2014-11-10 | FBR Capital | Market Perform | Maintains | |
| 2014-11-10 | Credit Suisse | Neutral | Maintains | |
| 2014-11-10 | Barclays | Equal-Weight | Maintains | |
| 2014-11-07 | Goldman Sachs | Sell | Neutral | Upgrade |
| 2014-09-22 | Citigroup | Sell | Maintains | |
| 2014-09-19 | JP Morgan | Overweight | Maintains | |
| 2014-08-07 | Raymond James | Outperform | Maintains | |
| 2014-07-31 | Credit Suisse | Neutral | Maintains | |
| 2014-07-31 | Barclays | Equal-Weight | Maintains | |
| 2014-07-16 | Deutsche Bank | Sell | Maintains | |
| 2014-06-27 | Sterne Agee | Neutral | Initiate | |
| 2014-06-06 | Stifel | Hold | Buy | Upgrade |
| 2014-05-23 | Leerink Swann | Outperform | Maintains | |
| 2014-05-22 | Argus Research | Buy | Maintains | |
| 2014-05-22 | Argus | Buy | Maintains | |
| 2014-05-09 | Raymond James | Outperform | Maintains | |
| 2014-05-08 | FBR Capital | Market Perform | Maintains | |
| 2014-05-08 | Credit Suisse | Neutral | Maintains | |
| 2014-05-08 | Barclays | Equal-Weight | Maintains | |
| 2014-05-08 | Bank of America | Neutral | Maintains | |
| 2014-03-07 | Jefferies | Buy | Hold | Downgrade |
| 2014-02-26 | Citigroup | Neutral | Sell | Downgrade |
| 2014-01-08 | Barclays | Overweight | Equal-weight | Downgrade |
| 2014-01-07 | Deutsche Bank | Hold | Sell | Downgrade |
| 2013-11-20 | Morgan Stanley | Equal-Weight | Initiate | |
| 2013-11-20 | JP Morgan | Overweight | Maintains | |
| 2013-11-19 | Leerink Swann | Outperform | Initiate | |
| 2013-11-13 | FBR Capital | Market Perform | Initiate | |
| 2013-11-07 | Jefferies | Buy | Maintains | |
| 2013-11-07 | Deutsche Bank | Hold | Maintains | |
| 2013-11-05 | Monness Crespi Hardt | Buy | Neutral | Downgrade |
| 2013-10-08 | Deutsche Bank | Hold | Maintains | |
| 2013-09-05 | JP Morgan | Overweight | Maintains | |
| 2013-08-01 | Stifel Nicolaus | Buy | Hold | Downgrade |
| 2013-08-01 | Jefferies | Buy | Maintains | |
| 2013-08-01 | Citigroup | Buy | Neutral | Downgrade |
| 2013-07-31 | Monness Crespi Hardt | Buy | Maintains | |
| 2013-07-16 | Deutsche Bank | Hold | Maintains | |
| 2013-07-10 | Jefferies | Buy | Maintains | |
| 2013-06-27 | Lazard | Neutral | Initiate | |
| 2013-05-10 | Monness Crespi Hardt | Buy | Maintains | |
| 2013-05-06 | JP Morgan | Neutral | Overweight | Upgrade |
| 2013-04-05 | UBS | Neutral | Initiate | |
| 2013-04-02 | Jefferies | Buy | Maintains | |
| 2013-04-02 | Deutsche Bank | Hold | Maintains | |
| 2013-02-26 | Deutsche Bank | Hold | Maintains | |
| 2013-02-05 | Jefferies | Buy | Maintains | |
| 2013-02-05 | Deutsche Bank | Hold | Maintains | |
| 2013-02-05 | BMO Capital | Market Perform | Maintains | |
| 2013-02-04 | Bank of America | Neutral | Maintains | |
| 2012-11-13 | Bank of America | Buy | Neutral | Downgrade |
| 2012-11-07 | Goldman Sachs | Neutral | Sell | Downgrade |
| 2012-11-07 | Bank of America | Buy | Neutral | Downgrade |
| 2012-11-06 | Jefferies | Buy | Maintains | |
| 2012-11-06 | Credit Suisse | Neutral | Maintains | |
| 2012-11-06 | BMO Capital | Market Perform | Maintains | |
| 2012-11-05 | Monness Crespi Hardt | Buy | Maintains | |
| 2012-10-15 | Deutsche Bank | Hold | Maintains | |
| 2012-08-30 | Credit Suisse | Outperform | Neutral | Downgrade |
| 2012-07-31 | Stifel Nicolaus | Buy | Maintains | |
| 2012-07-31 | Goldman Sachs | Neutral | Maintains | |
| 2012-07-31 | Deutsche Bank | Hold | Maintains | |
| 2012-07-31 | Citigroup | Buy | Maintains | |
| 2012-07-31 | Barclays | Equal-Weight | Maintains | |
| 2012-07-31 | Bank of America | Buy | Maintains | |
| 2012-05-01 | Jefferies | Buy | Maintains | |
| 2012-05-01 | Deutsche Bank | Hold | Maintains | |
| 2012-02-27 | Credit Suisse | Outperform | Maintains | |
| 2023-01-06 | JP Morgan | Overweight | Maintains | |
| 2023-02-06 | Cowen & Co. | Outperform | Maintains | |
| 2023-02-06 | Credit Suisse | Outperform | Maintains | |
| 2023-02-03 | Stephens & Co. | Overweight | Maintains | |
| 2023-02-02 | UBS | Buy | Maintains | |
| 2023-02-07 | Truist Securities | Hold | Maintains | |
| 2023-02-28 | Deutsche Bank | Buy | Maintains | |
| 2023-04-13 | Truist Securities | Hold | Maintains | |
| 2023-04-11 | Morgan Stanley | Overweight | Maintains | |
| 2023-04-21 | Cantor Fitzgerald | Overweight | Initiate | |
| 2023-05-02 | TD Cowen | Outperform | Maintains | |
| 2023-04-27 | Stephens & Co. | Overweight | Reiterate | |
| 2023-04-27 | SVB Securities | Outperform | Maintains | |
| 2023-04-27 | RBC Capital | Outperform | Reiterate | |
| 2023-04-27 | Oppenheimer | Outperform | Reiterate | |
| 2023-05-30 | JP Morgan | Overweight | Overweight | Maintains |
| 2023-06-15 | RBC Capital | Outperform | Outperform | Reiterate |
| 2023-06-20 | RBC Capital | Outperform | Outperform | Reiterate |
| 2023-06-20 | Truist Securities | Hold | Hold | Maintains |
| 2023-06-23 | Argus Research | Buy | Hold | Downgrade |
| 2023-08-03 | Truist Securities | Hold | Hold | Maintains |
| 2023-08-08 | Bernstein | Market Perform | Market Perform | Maintains |
| 2023-08-07 | Deutsche Bank | Buy | Buy | Maintains |
| 2024-03-22 | Raymond James | Market Perform | Initiate | |
| 2023-09-14 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-08-30 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-07-13 | UBS | Buy | Buy | Maintains |
| 2023-07-13 | Wells Fargo | Overweight | Overweight | Maintains |
| 2023-10-09 | Jefferies | Buy | Buy | Maintains |
| 2023-11-02 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-11-02 | Stephens & Co. | Overweight | Overweight | Maintains |
| 2023-11-02 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-07-11 | Mizuho | Buy | Buy | Maintains |
| 2024-04-02 | B of A Securities | Buy | Neutral | Downgrade |
| 2023-08-15 | TD Cowen | Outperform | Outperform | Maintains |
| 2024-04-02 | TD Cowen | Buy | Buy | Maintains |
| 2024-04-02 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2023-07-07 | JP Morgan | Overweight | Neutral | Downgrade |
| 2023-07-14 | Morgan Stanley | Overweight | Overweight | Reiterate |
| 2023-08-03 | RBC Capital | Outperform | Outperform | Maintains |
| 2023-08-03 | Stephens & Co. | Overweight | Overweight | Maintains |
| 2023-11-17 | JP Morgan | Neutral | Neutral | Maintains |
| 2023-11-21 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-12-12 | Argus Research | Hold | Buy | Upgrade |
| 2024-03-13 | Argus Research | Buy | Hold | Downgrade |
| 2024-04-04 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2024-01-30 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-04-25 | Cantor Fitzgerald | Neutral | Neutral | Maintains |
| 2024-04-25 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-01-26 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-01-26 | UBS | Buy | Neutral | Downgrade |
| 2024-01-26 | Stephens & Co. | Overweight | Overweight | Maintains |
| 2024-01-26 | Cantor Fitzgerald | Overweight | Neutral | Downgrade |
| 2024-01-26 | Mizuho | Buy | Buy | Maintains |
| 2024-01-26 | Goldman Sachs | Buy | Buy | Maintains |
| 2024-04-10 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2024-01-19 | Truist Securities | Hold | Hold | Reiterate |
| 2024-01-19 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-01-19 | Goldman Sachs | Buy | Buy | Maintains |
| 2024-01-19 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-04-25 | UBS | Neutral | Neutral | Maintains |
| 2024-04-25 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-05-20 | B of A Securities | Neutral | Neutral | Maintains |
| 2024-04-08 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-01-25 | Deutsche Bank | Buy | Hold | Downgrade |
| 2024-04-03 | Goldman Sachs | Buy | Buy | Maintains |
| 2024-04-22 | Jefferies | Buy | Buy | Maintains |
| 2024-01-29 | Goldman Sachs | Buy | Buy | Maintains |
| 2024-01-17 | Oppenheimer | Outperform | Outperform | Reiterate |
| 2024-03-06 | Barclays | Equal-Weight | Initiate | |
| 2024-05-30 | Baird | Neutral | Initiate | |
| 2024-06-12 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2024-07-15 | Truist Securities | Hold | Hold | Maintains |
| 2024-06-26 | Piper Sandler | Overweight | Initiate | |
| 2024-06-24 | Morgan Stanley | Equal-Weight | Initiate | |
| 2025-04-15 | Baird | Neutral | Neutral | Maintains |
| 2024-10-11 | Keybanc | Sector Weight | Initiate | |
| 2024-10-11 | Truist Securities | Hold | Hold | Maintains |
| 2024-08-02 | Deutsche Bank | Hold | Hold | Maintains |
| 2025-02-13 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-07-24 | TD Cowen | Buy | Buy | Maintains |
| 2024-10-02 | Leerink Partners | Outperform | Market Perform | Downgrade |
| 2024-10-02 | Stephens & Co. | Overweight | Equal-Weight | Downgrade |
| 2024-09-10 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2025-04-11 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-12-17 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-04-11 | Truist Securities | Hold | Hold | Maintains |
| 2024-10-07 | TD Cowen | Buy | Hold | Downgrade |
| 2024-10-07 | Jefferies | Buy | Hold | Downgrade |
| 2024-10-31 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-10-08 | Bernstein | Market Perform | Outperform | Upgrade |
| 2024-10-08 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-08-01 | Oppenheimer | Outperform | Outperform | Maintains |
| 2025-01-15 | Piper Sandler | Neutral | Neutral | Maintains |
| 2024-11-06 | B of A Securities | Underperform | Neutral | Upgrade |
| 2024-09-20 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2024-08-19 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2024-10-03 | Deutsche Bank | Hold | Hold | Maintains |
| 2024-10-03 | Piper Sandler | Overweight | Neutral | Downgrade |
| 2024-10-03 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-10-02 | B of A Securities | Neutral | Underperform | Downgrade |
| 2024-07-23 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2025-02-12 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2025-02-12 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-02-12 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-10-04 | UBS | Neutral | Neutral | Maintains |
| 2025-04-09 | Mizuho | Outperform | Outperform | Maintains |
| 2024-10-09 | Stephens & Co. | Equal-Weight | Equal-Weight | Reiterate |
| 2024-09-05 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-01-06 | Truist Securities | Hold | Hold | Maintains |
| 2024-08-21 | JP Morgan | Neutral | Neutral | Maintains |
| 2024-10-01 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2024-11-04 | TD Cowen | Hold | Hold | Maintains |
| 2024-11-04 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-01-22 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-10-10 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-02-18 | JP Morgan | Neutral | Neutral | Maintains |
| 2025-07-16 | Truist Securities | Hold | Hold | Maintains |
| 2025-08-21 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-04-09 | Guggenheim | Buy | Initiate | |
| 2025-08-14 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-08-14 | Argus Research | Hold | Hold | Reiterate |
| 2025-05-01 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2025-05-01 | Oppenheimer | Outperform | Outperform | Maintains |
| 2025-06-02 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-06-17 | B of A Securities | Neutral | Neutral | Maintains |
| 2025-06-17 | Truist Securities | Hold | Hold | Maintains |
| 2025-07-25 | Baird | Neutral | Neutral | Maintains |
| 2025-05-12 | Truist Securities | Hold | Hold | Maintains |
| 2025-07-31 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-07-31 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-07-31 | Piper Sandler | Neutral | Neutral | Maintains |
| 2025-06-12 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-09-05 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-09-02 | B of A Securities | Neutral | Neutral | Maintains |
| 2025-09-05 | Bernstein | Outperform | Outperform | Maintains |
